PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience
Background. In 2024, the EULAR published a set of points to consider for initiating targeted therapy in rheumatoid arthritis (RA) patients with a history of malignancy, indicating TNF inhibitors are preferred in solid tumors, while rituximab is recommended for hematological malignancies. Although t...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
PAGEPress Publications
2025-11-01
|
| Serier: | Reumatismo |
| Fag: | |
| Online adgang: | https://www.reumatismo.org/reuma/article/view/2021 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|